Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Penaeidae | 9 | 2019 | 13 | 2.69 | Why? |
| Roniviridae | 3 | 2019 | 3 | 1.09 | Why? |
| Memory, Short-Term | 2 | 2019 | 137 | 0.89 | Why? |
| Vibrio Infections | 2 | 2019 | 11 | 0.89 | Why? |
| Cognitive Remediation | 1 | 2019 | 14 | 0.79 | Why? |
| Mathematics | 1 | 2019 | 65 | 0.76 | Why? |
| Chitinases | 1 | 2017 | 8 | 0.73 | Why? |
| Vibrio | 1 | 2017 | 8 | 0.69 | Why? |
| Executive Function | 1 | 2019 | 173 | 0.66 | Why? |
| Tobacco | 1 | 2017 | 274 | 0.59 | Why? |
| Necrosis | 1 | 2017 | 532 | 0.53 | Why? |
| Pancreas | 1 | 2017 | 398 | 0.50 | Why? |
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 441 | 0.44 | Why? |
| Nocturnal Enuresis | 2 | 2018 | 5 | 0.39 | Why? |
| Iridoviridae | 2 | 2018 | 2 | 0.37 | Why? |
| Auditory Perception | 2 | 2017 | 32 | 0.34 | Why? |
| Brain | 3 | 2018 | 5133 | 0.30 | Why? |
| Aquaculture | 3 | 2018 | 12 | 0.27 | Why? |
| Evoked Potentials, Auditory | 3 | 2018 | 34 | 0.26 | Why? |
| Phylogeny | 6 | 2019 | 13341 | 0.24 | Why? |
| Liver | 1 | 2017 | 4007 | 0.23 | Why? |
| Vibrio parahaemolyticus | 1 | 2019 | 5 | 0.20 | Why? |
| Brain Mapping | 2 | 2018 | 228 | 0.19 | Why? |
| Therapy, Computer-Assisted | 1 | 2019 | 39 | 0.19 | Why? |
| Nidovirales Infections | 1 | 2018 | 17 | 0.19 | Why? |
| Iridovirus | 1 | 2017 | 1 | 0.19 | Why? |
| Salicylic Acid | 1 | 2017 | 10 | 0.18 | Why? |
| Oxylipins | 1 | 2017 | 29 | 0.18 | Why? |
| Cytochrome P-450 CYP3A Inhibitors | 1 | 2020 | 256 | 0.18 | Why? |
| Cyclopentanes | 1 | 2017 | 55 | 0.18 | Why? |
| Palaemonidae | 1 | 2017 | 4 | 0.18 | Why? |
| Nodaviridae | 1 | 2017 | 7 | 0.18 | Why? |
| Genome, Viral | 2 | 2017 | 13157 | 0.18 | Why? |
| Plants, Genetically Modified | 1 | 2017 | 84 | 0.17 | Why? |
| Basal Ganglia | 1 | 2017 | 49 | 0.17 | Why? |
| Bacterial Toxins | 1 | 2019 | 185 | 0.17 | Why? |
| Histocytochemistry | 1 | 2017 | 88 | 0.17 | Why? |
| Bile Ducts, Intrahepatic | 1 | 2017 | 68 | 0.17 | Why? |
| DNA, Ribosomal | 1 | 2017 | 112 | 0.17 | Why? |
| Nerve Net | 1 | 2018 | 118 | 0.17 | Why? |
| Plant Diseases | 1 | 2017 | 84 | 0.16 | Why? |
| Cerebellum | 1 | 2017 | 119 | 0.16 | Why? |
| Electroencephalography | 3 | 2018 | 1242 | 0.15 | Why? |
| Capsid Proteins | 1 | 2019 | 365 | 0.15 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.15 | Why? |
| Gene Editing | 1 | 2019 | 330 | 0.15 | Why? |
| Plant Proteins | 1 | 2017 | 194 | 0.15 | Why? |
| Sequence Homology | 1 | 2017 | 448 | 0.15 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2017 | 242 | 0.14 | Why? |
| Melanosomes | 1 | 2013 | 1 | 0.14 | Why? |
| Personality | 1 | 2018 | 277 | 0.14 | Why? |
| Hermanski-Pudlak Syndrome | 1 | 2013 | 5 | 0.14 | Why? |
| Cerebral Cortex | 1 | 2017 | 276 | 0.14 | Why? |
| Sequence Analysis, DNA | 3 | 2017 | 2830 | 0.13 | Why? |
| Retinal Pigment Epithelium | 1 | 2013 | 62 | 0.13 | Why? |
| RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.13 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2019 | 760 | 0.13 | Why? |
| Child Development | 1 | 2017 | 352 | 0.13 | Why? |
| Open Reading Frames | 2 | 2017 | 1898 | 0.12 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 800 | 0.12 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.12 | Why? |
| Base Sequence | 2 | 2017 | 3581 | 0.12 | Why? |
| Molecular Sequence Data | 1 | 2017 | 3198 | 0.11 | Why? |
| Sex Characteristics | 1 | 2017 | 1120 | 0.09 | Why? |
| Evoked Potentials | 2 | 2018 | 44 | 0.09 | Why? |
| Animals | 11 | 2019 | 78931 | 0.09 | Why? |
| Reaction Time | 2 | 2018 | 96 | 0.09 | Why? |
| DNA, Viral | 2 | 2017 | 2521 | 0.09 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.09 | Why? |
| Acoustic Stimulation | 2 | 2017 | 20 | 0.09 | Why? |
| Disaster Planning | 1 | 2021 | 1680 | 0.09 | Why? |
| China | 9 | 2021 | 50654 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Microscopy, Electron, Transmission | 2 | 2019 | 605 | 0.07 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Child | 4 | 2019 | 70012 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2019 | 6670 | 0.06 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Female | 13 | 2021 | 380317 | 0.05 | Why? |
| Comparative Genomic Hybridization | 1 | 2019 | 33 | 0.05 | Why? |
| Community Health Planning | 1 | 2021 | 164 | 0.05 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.05 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.05 | Why? |
| Hemocytes | 1 | 2017 | 19 | 0.05 | Why? |
| Cytomegalovirus | 1 | 2004 | 600 | 0.05 | Why? |
| Multilocus Sequence Typing | 1 | 2019 | 264 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2020 | 673 | 0.04 | Why? |
| Viral Proteins | 1 | 2017 | 7370 | 0.04 | Why? |
| Base Composition | 1 | 2017 | 203 | 0.04 | Why? |
| Tumor Microenvironment | 1 | 2019 | 264 | 0.04 | Why? |
| Cytomegalovirus Infections | 1 | 2004 | 667 | 0.04 | Why? |
| Memory Disorders | 1 | 2018 | 190 | 0.04 | Why? |
| Sequence Analysis | 1 | 2018 | 496 | 0.04 | Why? |
| Humans | 18 | 2021 | 930598 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2020 | 1654 | 0.04 | Why? |
| In Situ Hybridization | 1 | 2017 | 390 | 0.04 | Why? |
| Viral Matrix Proteins | 1 | 2004 | 1243 | 0.04 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.04 | Why? |
| Organ Dysfunction Scores | 1 | 2021 | 1475 | 0.04 | Why? |
| Monophenol Monooxygenase | 1 | 2013 | 11 | 0.04 | Why? |
| Cell- and Tissue-Based Therapy | 1 | 2019 | 422 | 0.04 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.03 | Why? |
| Virology | 1 | 2019 | 489 | 0.03 | Why? |
| Immunotherapy, Adoptive | 1 | 2019 | 524 | 0.03 | Why? |
| Cellular Senescence | 1 | 2017 | 326 | 0.03 | Why? |
| Aspartate Aminotransferases | 1 | 2021 | 1394 | 0.03 | Why? |
| Self Concept | 1 | 2018 | 490 | 0.03 | Why? |
| Prospective Studies | 1 | 2019 | 43301 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.03 | Why? |
| Phosphoproteins | 1 | 2004 | 4346 | 0.03 | Why? |
| Endothelial Cells | 1 | 2004 | 2048 | 0.03 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.03 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.03 | Why? |
| Polymerase Chain Reaction | 2 | 2018 | 6740 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Aged | 7 | 2021 | 215776 | 0.03 | Why? |
| Government | 1 | 2021 | 1453 | 0.03 | Why? |
| Blotting, Western | 1 | 2013 | 863 | 0.03 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.03 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.03 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.03 | Why? |
| CRISPR-Cas Systems | 1 | 2019 | 1397 | 0.03 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Personal Satisfaction | 1 | 2018 | 1243 | 0.02 | Why? |
| Cities | 1 | 2021 | 4937 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2019 | 3239 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Genomics | 1 | 2019 | 3118 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Infant, Newborn | 2 | 2017 | 23105 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2019 | 3607 | 0.02 | Why? |
| Immunotherapy | 1 | 2019 | 2421 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2019 | 3691 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Kidney Transplantation | 1 | 2004 | 5397 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2013 | 5542 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Phenotype | 1 | 2013 | 4037 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Leukocytes | 1 | 2004 | 1046 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2013 | 10998 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Mice | 1 | 2013 | 21357 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
Dong's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(188)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(155)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_